SAXENDA 6mg/ml – 3mg Pen (International English)
$475.00
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 - 5 | — | $475.00 |
| 6 - 10 | 0.42 % | $473.00 |
| 11 - 20 | 1.05 % | $470.00 |
| 21+ | 2.11 % | $465.00 |
SAXENDA® (liraglutide) is a GLP-1 receptor agonist indicated for chronic weight management in adults and adolescents. It comes in a 3 mL pre-filled pen containing 6 mg/mL of liraglutide, allowing for dose escalation up to 3 mg daily. SAXENDA® works by mimicking the action of glucagon-like peptide-1 (GLP-1), regulating appetite, delaying gastric emptying, and promoting satiety.
This prescription medication is approved for adults with a BMI ≥30 kg/m², or ≥27 kg/m² with comorbidities (e.g., type 2 diabetes, hypertension), and adolescents aged 12 years or older with obesity and weight >60 kg. When combined with a calorie-restricted diet and increased physical activity, SAXENDA® supports clinically significant weight loss and reduces cardiometabolic risk factors.


